| http://www.w3.org/ns/prov#value | - Aside from the basics that we reported yesterday, here are some snippets from various stories.Eli Kintisch of ScienceNow noted that Harvard pancreatic cell researcher Doug Melton calls WARF's licensing terms 'onerous, restrictive, and uncooperative.'Reporter Jim Downing of The Sacramento Bee wrote:Negotiating patents and licenses is an everyday part of biotech research and development.
|
